Harvard Bioscience
HBIO
#8485
Rank
A$0.17 B
Marketcap
$4.03
Share price
-1.10%
Change (1 day)
-39.69%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of June 2024 : A$6.07 M

According to Harvard Bioscience's latest financial reports the company has A$6.07 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$6.28 M-5.1%
2022-12-31A$6.62 M-38.41%
2021-12-31A$10.75 M-0.34%
2020-12-31A$10.79 M-8.97%
2019-12-31A$11.85 M2.24%
2018-12-31A$11.59 M74.39%
2017-12-31A$6.65 M-14.34%
2016-12-31A$7.76 M-16.15%
2015-12-31A$9.25 M-46.29%
2014-12-31A$17.23 M-40.34%
2013-12-31A$28.89 M44.85%
2012-12-31A$19.94 M14.16%
2011-12-31A$17.47 M-10.22%
2010-12-31A$19.46 M4.93%
2009-12-31A$18.54 M-6.49%
2008-12-31A$19.83 M-3.12%
2007-12-31A$20.47 M72.48%
2006-12-31A$11.86 M13.8%
2005-12-31A$10.43 M-41.79%
2004-12-31A$17.91 M61.98%
2003-12-31A$11.06 M-59.3%
2002-12-31A$27.17 M-52.8%
2001-12-31A$57.57 M-10.12%
2000-12-31A$64.06 M1656.86%
1999-12-31A$3.64 M133.29%
1998-12-31A$1.56 M